RANO Criteria
Author:
Publisher
Elsevier
Reference96 articles.
1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005
2. An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma;Norden;J Neurooncol,2009
3. Recurrent glioblastoma: a fresh look at current therapies and emerging novel approaches;Gilbert;Seminars Oncol,2011
4. Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial;Ellingson;Radiology,2014
5. Imaging biomarkers for antiangiogenic therapy in malignant gliomas;Leu;CNS Oncol,2013
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Phase I trial of single-agent recombinant human anti-vascular endothelial growth factor (GB222) followed a combination therapy of GB222 and temozolomide in patients with recurrent WHO grade III and IV glioma;Current Medicine;2022-07-04
2. Association of plasma levetiracetam concentration, MGMT methylation and sex with survival of chemoradiotherapy-treated glioblastoma patients;Pharmacological Research;2022-07
3. Glioblastoma: Molecular profile and immunophenotypic analysis as prognostic tools for tailored therapy and decision making in a recent surgical series;Interdisciplinary Neurosurgery;2020-06
4. The biology and mathematical modelling of glioma invasion: a review;Journal of The Royal Society Interface;2017-11
5. Superselective Intra-arterial Cerebral Infusion for High Grade Gliomas: Potential Imaging Biomarkers of Response;World Neurosurgery;2017-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3